Literature DB >> 24355524

Stathmin 1 is involved in the highly proliferative phenotype of high-risk myelodysplastic syndromes and acute leukemia cells.

João Agostinho Machado-Neto1, Paula de Melo Campos1, Patricia Favaro2, Mariana Lazarini1, Irene Lorand-Metze1, Fernando Ferreira Costa1, Sara Teresinha Olalla Saad1, Fabiola Traina3.   

Abstract

Stathmin 1 is an important cytoplasmic microtubule-destabilizing protein that plays critical roles in proliferation and accurate chromosome segregation through regulation of microtubule dynamics. High levels of Stathmin 1 expression have been reported in leukemia and solid tumors. However, Stathmin 1 has not been studied in myelodysplastic syndrome cells. We, herein, report that significantly higher Stathmin 1 levels were observed in proliferating hematopoietic cells, in high-risk MDS and acute leukemia cells. In addition, Stathmin 1 silencing in U937 and Namalwa leukemia cells reduced cell proliferation and clonogenicity. Our data suggest that Stathmin 1 expression may be related to the highly proliferative phenotype of hematopoietic cells and add new insights into the participation of Stathmin 1 in hematological malignancies.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Acute lymphoid leukemia; Acute myeloid leukemia; Myelodysplastic syndromes; OP18; Stathmin 1

Mesh:

Substances:

Year:  2013        PMID: 24355524     DOI: 10.1016/j.leukres.2013.11.013

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  13 in total

1.  BNIP3L in myelodysplastic syndromes and acute myeloid leukemia: impact on disease outcome and cellular response to decitabine.

Authors:  Mariana Lazarini; João Agostinho Machado-Neto; Adriana da Silva Santos Duarte; Fernando Vieira Pericole; Karla Priscila Vieira; Fernanda S Niemann; Marisa Alvarez; Fabiola Traina; Sara Teresinha Olalla Saad
Journal:  Haematologica       Date:  2016-07-21       Impact factor: 9.941

2.  The Microtubule Network and Cell Death Are Regulated by an miR-34a/Stathmin 1/βIII-Tubulin Axis.

Authors:  Nancy S Vetter; E A Kolb; Christopher C Mills; Valerie B Sampson
Journal:  Mol Cancer Res       Date:  2017-03-08       Impact factor: 5.852

3.  High expression of stathmin 1 is a strong prognostic marker in oral squamous cell carcinoma patients treated by docetaxel-containing regimens.

Authors:  Koji Harada; Tarannum Ferdous; Toyoko Harada; Yoshiya Ueyama
Journal:  Clin Exp Med       Date:  2015-11-21       Impact factor: 3.984

4.  Stathmin 1 inhibition amplifies ruxolitinib-induced apoptosis in JAK2V617F cells.

Authors:  João Agostinho Machado-Neto; Paula de Melo Campos; Patricia Favaro; Mariana Lazarini; Adriana da Silva Santos Duarte; Irene Lorand-Metze; Fernando Ferreira Costa; Sara Teresinha Olalla Saad; Fabiola Traina
Journal:  Oncotarget       Date:  2015-10-06

5.  Paclitaxel induces Stathmin 1 phosphorylation, microtubule stability and apoptosis in acute lymphoblastic leukemia cells.

Authors:  João Agostinho Machado-Neto; Ana Paula Nunes Rodrigues Alves; Jaqueline Cristina Fernandes; Juan Luiz Coelho-Silva; Renata Scopim-Ribeiro; Bruna Alves Fenerich; Fernanda Borges da Silva; Priscila Santos Scheucher; Belinda Pinto Simões; Eduardo Magalhães Rego; Fabiola Traina
Journal:  Heliyon       Date:  2017-09-28

6.  Single SNP- and pathway-based genome-wide association studies for beak deformity in chickens using high-density 600K SNP arrays.

Authors:  Hao Bai; Yanyan Sun; Nian Liu; Fuguang Xue; Yunlei Li; Songshan Xu; Jianhua Ye; Lei Zhang; Yu Chen; Jilan Chen
Journal:  BMC Genomics       Date:  2018-06-28       Impact factor: 3.969

Review 7.  Stathmin 1 in normal and malignant hematopoiesis.

Authors:  João Agostinho Machado-Neto; Sara Teresinha Olalla Saad; Fabiola Traina
Journal:  BMB Rep       Date:  2014-12       Impact factor: 4.778

Review 8.  Stathmin-dependent molecular targeting therapy for malignant tumor: the latest 5 years' discoveries and developments.

Authors:  Rong Biaoxue; Cai Xiguang; Liu Hua; Yang Shuanying
Journal:  J Transl Med       Date:  2016-09-27       Impact factor: 5.531

9.  Immune microenvironment of experimental rat C6 gliomas resembles human glioblastomas.

Authors:  Anna Gieryng; Dominika Pszczolkowska; Katarzyna Bocian; Michal Dabrowski; Wenson David Rajan; Michal Kloss; Jakub Mieczkowski; Bozena Kaminska
Journal:  Sci Rep       Date:  2017-12-14       Impact factor: 4.379

10.  Stathmin 1 expression in plasma cell neoplasms.

Authors:  João Agostinho Machado-Neto; Fernando Vieira Pericole; Fernando Ferreira Costa; Fabiola Traina; Sara Teresinha Olalla Saad
Journal:  Rev Bras Hematol Hemoter       Date:  2017-03-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.